Stefanie Nöpel‐Dünnebacke

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma

Alexander Baraniskin, Stefanie Nöpel‐Dünnebacke, Maike Ahrens et al. · International Journal of Cancer · 2012 · 144 citations

Medicine, Molecular Biology, Oncology +17

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma

Alexander Baraniskin, Elena Zaslavska, Stefanie Nöpel‐Dünnebacke et al. · Neuro-Oncology · 2015 · 48 citations · Full text

Medicine, Molecular Biology, Oncology +17

Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients

Jens Köhler, Martin Schüler, Thomas Gauler et al. · Journal of Cancer Research and Clinical Oncology · 2015 · 45 citations · Full text

Medicine, Molecular Biology, Oncology +16

Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial

Susanna Hegewisch‐Becker, Stefanie Nöpel‐Dünnebacke, Axel Hinke et al. · European Journal of Cancer · 2018 · 22 citations

Medicine, Oncology, Pharmacotherapy +15

Analysis of U2 Small Nuclear RNA Fragments in the Bile Differentiates Cholangiocarcinoma from Primary Sclerosing Cholangitis and Other Benign Biliary Disorders

Alexander Baraniskin, Stefanie Nöpel‐Dünnebacke, Brigitte Schumacher et al. · Digestive Diseases and Sciences · 2014 · 21 citations

Medicine, Molecular Biology, Pathology +11